FMP

FMP

Enter

NRXPW - NRx Pharmaceuticals,...

Terminal Value of NRx Pharmaceuticals, Inc.(NRXPW), NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for

photo-url-https://financialmodelingprep.com/image-stock/NRXPW.png

NRx Pharmaceuticals, Inc.

NRXPW

NASDAQ

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.

0.072 USD

-0.0224 (-31.11%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep